Clinical Metabolomics


Clinical metabolomics involves the application of clinical laboratory protocols, standards, and oversight of a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways. Examples of such diseases include diabetes, cancer as well as infectious diseases and neurodegenerative diseases. Within metabolomics, lipidomics has its own identity. Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.



 


    Related Conference of Clinical Metabolomics

    March 07-08, 2024

    14th World Glycobiology Congress

    Toronto, Canada
    March 28-29, 2024

    6th International Conference on Biochemistry

    Dubai, UAE
    May 16-17, 2024

    30th Asia Pacific Biotechnology Congress

    Rome, Italy
    September 25-26, 2024

    20th World Congress on Structural Biology

    Paris, France

    Clinical Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in